Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
作者信息
de Clercq E, Degreef H, Wildiers J, de Jonge G, Drochmans A, Descamps J, de Somer P
出版信息
Br Med J. 1980 Nov 1;281(6249):1178. doi: 10.1136/bmj.281.6249.1178.
Abstract
摘要
相似文献
1
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.口服（E）-5-（2-溴乙烯基）-2'-脱氧尿苷治疗重症带状疱疹
Br Med J. 1980 Nov 1;281(6249):1178. doi: 10.1136/bmj.281.6249.1178.
2
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine treatment of severe herpes zoster in cancer patients.口服（E）-5-（2-溴乙烯基）-2'-脱氧尿苷治疗癌症患者的严重带状疱疹
Eur J Cancer Clin Oncol. 1984 Apr;20(4):471-6. doi: 10.1016/0277-5379(84)90231-1.
3
Oral BVDU treatment of varicella and zoster in children with cancer.口服BVDU治疗癌症患儿的水痘和带状疱疹。
Eur J Pediatr. 1985 Jan;143(3):198-202. doi: 10.1007/BF00442138.
4
Brivudin (bromovinyl deoxyuridine).布立伏定（溴乙烯基脱氧尿苷）。
Drugs. 2004;64(18):2091-7; discussion 2098-9. doi: 10.2165/00003495-200464180-00011.
5
[5-(2-bromovinyl)-2'-deoxyuridine therapy of herpes zoster diseases in patients with malignant primary diseases].[5 -（2 - 溴乙烯基）- 2'-脱氧尿苷治疗伴有原发性恶性疾病的带状疱疹疾病]
Z Gesamte Inn Med. 1988 Dec 1;43(23):677-80.
6
Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2'-deoxyuridine.用（E）-5-（2-溴乙烯基）-2'-脱氧尿苷对实验性单纯疱疹病毒1型生殖器疱疹进行口服和局部治疗。
J Antimicrob Chemother. 1984 Aug;14 Suppl A:111-8. doi: 10.1093/jac/14.suppl_a.111.
7
Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.BVDU（布立伏定）作为治疗带状疱疹的药物的发现与研发。
Biochem Pharmacol. 2004 Dec 15;68(12):2301-15. doi: 10.1016/j.bcp.2004.07.039.
8
Preliminary results of oral BVDU treatment of herpes zoster ophthalmicus.口服BVDU治疗眼部带状疱疹的初步结果。
Bull Soc Belge Ophtalmol. 1981;193:49-56.
9
Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine.水痘-带状疱疹病毒感染的治疗——（E）-5-（2-溴乙烯基）-2'-脱氧尿苷的作用机制
Antiviral Res. 1985;Suppl 1:35-44. doi: 10.1016/s0166-3542(85)80006-1.
10
Herpes zoster guidelines of the German Dermatological Society.德国皮肤病学会带状疱疹指南。
J Clin Virol. 2003 Aug;27(3):308-9. doi: 10.1016/s1386-6532(03)00125-2.
引用本文的文献
1
Sixty Years at the Rega Institute.鲁汶大学雷加研究所的六十年
Viruses. 2025 Feb 5;17(2):222. doi: 10.3390/v17020222.
2
Selected Milestones in Antiviral Drug Development.抗病毒药物研发的重要里程碑
Viruses. 2024 Jan 23;16(2):169. doi: 10.3390/v16020169.
3
Hydrogen Bonding (Base Pairing) in Antiviral Activity.氢键（碱基配对）在抗病毒活性中的作用。
Viruses. 2023 May 10;15(5):1145. doi: 10.3390/v15051145.
4
The development of BVDU: An odyssey.BVDU 的发展：一段奇遇。
Antivir Chem Chemother. 2023 Jan-Dec;31:20402066231152971. doi: 10.1177/20402066231152971.
5
Reflections on the Rega Institute for Medical Research, at the fiftieth anniversary of the Rega Stichting vzw (Rega Instituut vzw, Rega Foundation).雷吉奥医学研究协会五十周年纪念文集（雷吉奥协会 vzw，雷吉奥基金会）。
Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221129979. doi: 10.1177/20402066221129979.
6
Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq.对抗病毒研究与药物开发的毕生热情：埃里克·德·克勒克教授八十华诞
Biochem Pharmacol. 2021 Mar;185:114485. doi: 10.1016/j.bcp.2021.114485. Epub 2021 Feb 20.
7
Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday.核苷（酸）类抗病毒药物的发现：谨以此书献给埃里克·德·克勒克教授 80 华诞。
Molecules. 2021 Feb 9;26(4):923. doi: 10.3390/molecules26040923.
8
An Odyssey in antiviral drug development-50 years at the Rega Institute: 1964-2014.抗病毒药物研发的奥德赛之旅——鲁加研究所的50年：1964 - 2014年
Acta Pharm Sin B. 2015 Nov;5(6):520-43. doi: 10.1016/j.apsb.2015.09.001. Epub 2015 Nov 2.
9
Analysis and prediction of highly effective antiviral peptides based on random forests.基于随机森林的高效抗病毒肽分析与预测。
PLoS One. 2013 Aug 5;8(8):e70166. doi: 10.1371/journal.pone.0070166. Print 2013.
10
Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase.基于工程化的人脱氧胞苷激酶变体的细胞命运控制基因治疗。
Mol Ther. 2012 May;20(5):1002-13. doi: 10.1038/mt.2011.298. Epub 2012 Jan 24.
本文引用的文献
1
(E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.（E）-5-（2-溴乙烯基）-2'-脱氧尿苷治疗实验性单纯疱疹性角膜炎
Antimicrob Agents Chemother. 1980 Jan;17(1):8-12. doi: 10.1128/AAC.17.1.8.
2
Pharmacokinetics of E-5-(2-bromovinyl)-2'-deoxyuridine in mice.E-5-(2-溴乙烯基)-2'-脱氧尿苷在小鼠体内的药代动力学
Antimicrob Agents Chemother. 1979 Aug;16(2):234-6. doi: 10.1128/AAC.16.2.234.
3
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.（E）-5-（2-溴乙烯基）-2'-脱氧尿苷：一种高效且选择性的抗疱疹药物。
Proc Natl Acad Sci U S A. 1979 Jun;76(6):2947-51. doi: 10.1073/pnas.76.6.2947.
4
Parenteral acyclovir therapy for herpesvirus infections in man.人疱疹病毒感染的阿昔洛韦胃肠外给药治疗
Lancet. 1979 Dec 15;2(8155):1267-70. doi: 10.1016/s0140-6736(79)92281-5.
Zotero 插件